REQUEST A DEMO
Total
USD $0.00
Search more companies

MAB Pharma Zrt. (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: MAB Pharma Zrt. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

MAB Pharma Zrt. is a company in Hungary, with a head office in Torokbalint. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on February 27, 2012. 12 (2024) employees currently work for MAB Pharma Zrt.. The company’s latest financial report indicates a net sales revenue drop of 8.47% in 2024. There was a total growth of 10.55% in MAB Pharma Zrt.’s total assets over the same period. In 2024, MAB Pharma Zrt.’s net profit margin decreased by 3.15%.

Headquarters
Torbagy utca 24.
Torokbalint; Pest; Postal Code: 2045

Contact Details: Purchase the MAB Pharma Zrt. report to view the information.

Website: http://www.mab-pharma.hu

Basic Information
Total Employees:
Purchase the MAB Pharma Zrt. report to view the information.
Registered Capital:
Purchase the MAB Pharma Zrt. report to view the information.
Financial Auditors:
Purchase the MAB Pharma Zrt. report to view the information.
Incorporation Date:
February 27, 2012
Key Executives
Purchase this report to view the information.
Member of Board of Directors
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Manager
Company Performance
Financial values in the chart are available after MAB Pharma Zrt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-8.47%
Total Operating Revenue
-3.62%
Operating Profit
-78.99%
EBITDA
35.89%
Net Profit/Loss for the Period
-78.71%
Total Assets
10.55%
Total Equity
1.26%
Operating Profit Margin
-0.94%
Net Profit Margin
-3.15%
Return on Equity (ROE)
-4.68%
Debt / Equity
7576%
Quick Ratio
171.02%
Cash Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?